Moderna announced on Wednesday that it has filed an emergency use authorization request with the U.S. Food and Drug Administration for its COVID-19 booster to be expanded to all adults 18 and older.
In October, the FDA approved emergency use authorization of Moderna’s COVID-19 booster for people 65 and older and people 18 to 64 who are at high risk for severe COVID-19, according to a company news release.
Moderna’s request comes just a little over a week after Pfizer submitted a similar emergency use authorization request to the FDA on Nov. 9, asking the agency to expand access to its booster shot to all adults over age 18.
FILE - A nurse shows the vial of the Moderna novel Coronavirus vaccine.
Check back for updates.